de Koning EJP - Search Results

1

Oxidative Stress Leads to β-Cell Dysfunction Through Loss of β-Cell Identity.

Leenders F, Groen N, de Graaf N, Engelse MA, Rabelink TJ, de Koning EJP, Carlotti F. Leenders F, et al. Among authors: de koning ejp, de graaf n. Front Immunol. 2021 Nov 4;12:690379. doi: 10.3389/fimmu.2021.690379. eCollection 2021. Front Immunol. 2021. PMID: 34804002 Free PMC article.

2

Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes.

van Etten RW, de Koning EJ, Honing ML, Stroes ES, Gaillard CA, Rabelink TJ. van Etten RW, et al. Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):799-804. doi: 10.1161/01.atv.0000015330.64968.c4. Arterioscler Thromb Vasc Biol. 2002. PMID: 12006393

3

Endothelial function in the post-prandial state.

de Koning EJ, Rabelink TJ. de Koning EJ, et al. Atheroscler Suppl. 2002 May;3(1):11-6. doi: 10.1016/s1567-5688(01)00008-3. Atheroscler Suppl. 2002. PMID: 12044580 Review.

4

Metabolic and additional vascular effects of thiazolidinediones.

Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ. Martens FM, et al. Drugs. 2002;62(10):1463-80. doi: 10.2165/00003495-200262100-00004. Drugs. 2002. PMID: 12093315 Review.

5

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ. van Etten RW, et al. Diabetologia. 2002 Jul;45(7):1004-10. doi: 10.1007/s00125-002-0862-1. Epub 2002 Jun 6. Diabetologia. 2002. PMID: 12136399 Clinical Trial.

6

Postprandial recruitment of neutrophils may contribute to endothelial dysfunction.

van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, Castro Cabezas M. van Oostrom AJ, et al. J Lipid Res. 2003 Mar;44(3):576-83. doi: 10.1194/jlr.M200419-JLR200. Epub 2002 Dec 16. J Lipid Res. 2003. PMID: 12562833 Free article. Clinical Trial.

7

Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms.

Prinsen BH, de Sain-van der Velden MG, de Koning EJ, Koomans HA, Berger R, Rabelink TJ. Prinsen BH, et al. Kidney Int Suppl. 2003 May;(84):S121-4. doi: 10.1046/j.1523-1755.63.s84.34.x. Kidney Int Suppl. 2003. PMID: 12694325 Free article. Review.

8

Thiazolidinediones and blood lipids in type 2 diabetes.

van Wijk JP, de Koning EJ, Martens EP, Rabelink TJ. van Wijk JP, et al. Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1744-9. doi: 10.1161/01.ATV.0000090521.25968.4D. Epub 2003 Aug 7. Arterioscler Thromb Vasc Biol. 2003. PMID: 12907465

9

Microvessel haemodynamics: interesting news which is not NO news?

de Koning EJ, Rabelink TJ. de Koning EJ, et al. Eur Heart J. 2003 Dec;24(23):2081-2. doi: 10.1016/j.ehj.2003.09.001. Eur Heart J. 2003. PMID: 14643267 No abstract available.

10

Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Loomans CJ, et al. Diabetes. 2004 Jan;53(1):195-9. doi: 10.2337/diabetes.53.1.195. Diabetes. 2004. PMID: 14693715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters